Bassil, Anna K.,Beinke, Soren,Prinjha, Rabinder Kumar
申请号：
AU2012332297
公开号：
AU2012332297A1
申请日:
2012.11.02
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
The present invention relates to a method of treating T cell mediated inflammatory immune diseases or T cell mediated hypersensitivity diseases, which comprises administering to a human in need thereof an effective amount of a compound which inhibits EZH2 and/or EZH1, or a pharmaceutically acceptable salt thereof.
